Fig. 3From: Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cancer patientsOther WES data of HE and HI. A TMB levels of HE and HI; BÂ MATH levels of HE and HI; CÂ MSI status of HE and HI; DÂ CNV burden of HE and HI; EÂ CNI levels of HE and HIBack to article page